Data from EMC - Curated by Toby Galbraith - Last updated 17 March 2017

Licensing authority

EMA (European Medicines Agency)

Indication(s)

Ledaga is indicated for the topical treatment of mycosis fungoides-type cutaneous T-cell lymphoma (MF-type CTCL) in adult patients.

Full Prescribing information

Learning Zones

An epgonline.org Learning Zone (LZ) is an area of the site dedicated to providing detailed self-directed medical education about a disease, condition or procedure.

IL-17A in Psoriasis

Experts discuss new targeted therapies for psoriasis at the European Association of Dermatology and Venereology (EADV) Congress 2015

Visit IL-17A in Psoriasis

More information

Category Value
Agency product number EMEA/H/C/002826
Orphan designation Yes
Date First Approved 03-03-2017
Type POM
Marketing authorisation holder Actelion Registration Ltd.

Related Content